Bourse
Stock filings

BCDA insider trades & Congress trades

BioCardia, Inc.: public insider filings and Congress disclosures, in one place.

7insider buys + sells
0Congress trades
7 / 0insider buys / sells, 90 days
–latest buying cluster

Bourse has recorded 7 open-market insider transactions in BioCardia, Inc. (BCDA) (7 purchases with code P and 0 sales with code S), the most recent on October 16, 2026.

In the last 90 days: 7 purchases by 1 insider ($11K) and 0 sales by 0 ($0).

Insider transactions

SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.

DateInsiderRoleTypeSharesPriceValueAfter 1M
Oct 16, 2026Altman PeterPresident and CEOBuy300$0.95$285–
Oct 15, 2026Altman PeterPresident and CEOBuy200$0.95$190–
Sep 29, 2026Altman PeterPresident and CEOBuy1,000$1.03$1K−0.1%
Sep 23, 2026Altman PeterPresident and CEOBuy1,900$1.05$2K–
Sep 3, 2026Altman PeterPresident and CEOBuy800$1.09$872−0.0%
Aug 17, 2026Altman PeterPresident and CEOBuy5,400$0.93$5K+0.2%
Aug 13, 2026Altman PeterPresident and CEOBuy1,900$0.92$2K+0.3%

Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.

New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.

See these filings as they land

Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.

Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.